Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia

ANZ Journal of Surgery

Volumn 74, Issue 3, 2004, Pages 139-142

  Fraser, John F ^a   Cuttle, Leila ^a   Kempf, Margit ^a   Kimble, Roy M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antimicrobial; Burn; Cytotoxicity; Sepsis; Wound healing

Indexed keywords

ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; SILVAZINE; SULFADIAZINE SILVER;

ARTICLE; BURN; CELL COUNT; CELL CULTURE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; TIME SERIES ANALYSIS; WOUND HEALING;

ANTI-INFECTIVE AGENTS, LOCAL; AUSTRALASIA; BANDAGES; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CHLORHEXIDINE; DRUG COMBINATIONS; HUMANS; KERATINOCYTES; POLYESTERS; POLYETHYLENES; SILVER SULFADIAZINE;

EID: 1842455718     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2004.02916.x     Document Type: Article

References (22)

1. Hettich R. Interactions between local and generalised burn edema. Resuscitation 1986; 14: 105-12.
2. Pruitt BA Jr, O'Neill JA Jr, Moncrief JA, Lindberg RB. Successful control of burn-wound sepsis. Jama 1968; 203: 1054-6.
3. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: current status. World J. Surg. 1998; 22: 135-45.
4. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000; 26: 131-8.
5. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000; 26: 117-30.
6. Clarke AM, Solomon J, Keogh J, Nixon M, Burchett J. Chlorhexidine with silver-sulphadiazine in the treatment of burns. Med. J. Aust. 1971; 2: 446.
7. Clarke AM. Topical use of silver sulphadiazine and chlorhexidine in the prevention of infection in thermal injuries. Med. J. Aust. 1975; 1: 413-15.
8. George N, Faoagali J, Muller M. Silvazine (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns 1997; 23: 493-5.
9. Gray JH, Henry DA, Forbes M, Germann E, Roberts FJ, Snelling CF. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds. Burns 1991; 17: 37-40.
10. Inman RJ, Snelling CF, Roberts FJ, Shaw K, Boyle JC. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection. Burns Incl. Therm. Inj. 1984; 11: 35-40.
11. Steen M. Review of the use of povidone-iodine (PVP-I) in the treatment of burns. Postgrad Med. J. 1993; 69: S84-92.
12. al-Tannir MA, Goodman HS. A review of chlorhexidine and its use in special populations. Spec. Care Dentist 1994; 14: 116-22.
13. Hidalgo E, Dominguez C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol. In Vitro 2001; 15: 271-6.
14. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit. Rev. Toxicol. 1996; 26: 255-60.
15. Lockhart SP, Rushworth A, Azmy AA, Raine PA. Topical silver sulphadiazine: side effects and urinary excretion. Burns Incl. Therm. Inj. 1983; 10: 9-12.
16. Maitre S, Jaber K, Perrot JL, Guy C, Cambazard F. Increased serum and urinary levels of silver during treatment with topical silver sulfadiazine. Ann. Dermatol. Venereol. 2002; 129: 217-19.
17. Ortiz JE, Horn MS, Peterson HD. Toxic epidermal necrolysis-case report and review of the literature. Ann. Plast. Surg. 1982; 9: 249-53.
18. Sawada Y. Adverse reaction to sulphonamides in a burned patient: a case report. Burns Incl. Therm. Inj. 1985; 12: 127-31.
19. McDonnell G, Russell AD. Antiseptics and disinfectants: Activity, Action, Resistance. Clin. Microbiol. Rev. 1999; 12: 147-79.
20. Gasset AR, Ishii Y. Cytotoxicity of chlorhexidine. Can. J. Ophthalmol. 1975; 10: 98-100.
21. Wilken R, Botha SJ, Grobler A, Germishuys PJ. In vitro cytotoxicity of chlorhexidine gluconate, benzydamine-HCl and povidone iodine mouth rinses on human gingival fibroblasts. Sadj 2001; 56: 455-60.
22. Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM. An in vitro study of the antimicrobial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream and a silver coated dressing. Burns 2004; 30: 35-41.